Clinical Trial Update: Sensoril(Ashwaganhda)for Bipolar Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial of Sensoril (ashwagandha extract) for bipolar disorder has completed; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Bipolar Disorder Nos
• Bipolar Ii Disorder

Drugs mentioned

• Sensoril (Withania somnifera extract)

Snippet

Sponsor: University of Pittsburgh | Conditions: Bipolar I Disorder, Bipolar II Disorder | Phase 3 | Status: COMPLETED | Results posted: 2016-04-14